Skip to content

COVID-19 is an emerging, rapidly evolving situation.

Get the latest public health information from CDC:
Get the latest research information from NIH:

BSC Counselor - Patricio O’Donnell, M.D., Ph.D.

Patricio O’Donnell, M.D., Ph.D. is Executive Medical Director in the Translational Research and Early Clinical group at Takeda Pharmaceuticals. He received his M.D. and Ph.D. (in Physiology) degrees from the University of Buenos Aires, Argentina. After a residency in Internal Medicine, he did a postdoctoral fellowship at the University of Pittsburgh with Tony Grace. He spent the next 16 years in academia, first at Albany Medical College and later at the University of Maryland School of Medicine. His academic career focused on translational studies to understand the neuronal circuitry implicated in neuropsychiatric disorders. In 2013, Patricio was recruited by Pfizer to lead discovery efforts for psychiatric indications. In that role, he led a variety of internal efforts and external collaborations aimed at identifying genetically-informed novel targets, as well as finding biomarkers for patient stratification. At Takeda, he leads similar efforts with a focus on identifying neurophysiology-based biomarkers for drug development for psychiatric indications. Patricio holds adjunct appointments at McLean Hospital and Harvard University Department of Psychiatry.